{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:10:36Z","timestamp":1790071836017,"version":"4.0.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T00:00:00Z","timestamp":1754438400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Health Popul Nutr"],"DOI":"10.1186\/s41043-025-01033-8","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T11:30:24Z","timestamp":1754479824000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Economic burden and quality of life caused by non-hodgkin lymphoma cancer in Iran"],"prefix":"10.1186","volume":"44","author":[{"given":"Marzieh","family":"Ghiasi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein-Ali","family":"Nikbakht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3767-9921","authenticated-orcid":false,"given":"Amirmohammad","family":"Tajik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Ghavami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roham","family":"Salek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboubeh","family":"Darabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Mohammadnabizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Morteza","family":"Mojtabaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2035-6587","authenticated-orcid":false,"given":"Farshad","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6249-821X","authenticated-orcid":false,"given":"Mehdi","family":"Varmaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,6]]},"reference":[{"issue":"10100","key":"1033_CR1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","volume":"390","author":"T Vos","year":"2017","unstructured":"Vos T, Abajobir AA, Abate KH, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and National incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211\u201359.","journal-title":"Lancet"},{"issue":"4","key":"1033_CR2","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","volume":"3","author":"C Fitzmaurice","year":"2017","unstructured":"Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and National cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 2017;3(4):524\u201348.","journal-title":"JAMA Oncol"},{"issue":"6","key":"1033_CR3","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"Cancer J Clin"},{"key":"1033_CR4","unstructured":"Fouladseresht H, Ghorbani M, Hassanipour S, Delam H, Mokhtari A, Mohseni S et al. The incidence of non-hodgkin lymphoma in iran: a systematic review and meta-analysis. World Cancer Res J. 2019;6:e1261"},{"issue":"1","key":"1033_CR5","first-page":"1","volume":"31","author":"M Varmaghani","year":"2023","unstructured":"Varmaghani M, Elyasi S, Mojahedian MM, Ghavami V, Borhani B, Javan-Noughabi J, et al. Availability and affordability of anticancer medicines in Iran based on WHO\/HAI standard survey methods. Support Care Cancer. 2023;31(1):1\u20139.","journal-title":"Support Care Cancer"},{"issue":"6","key":"1033_CR6","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMra1110897","volume":"370","author":"A Mills","year":"2014","unstructured":"Mills A. Health care systems in low-and middle-income countries. New Engl J Med. 2014;370(6):552\u20137.","journal-title":"New Engl J Med"},{"key":"1033_CR7","unstructured":"Bloom DE, Cafiero E, Jan\u00e9-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of noncommunicable diseases. Program on the Global Demography of Aging; 2012."},{"issue":"7","key":"1033_CR8","first-page":"1","volume":"19","author":"M Bayat","year":"2017","unstructured":"Bayat M, Harirchi I, Salehi Zalani G, Akbari-Sari A, Shokri A, Khodadost M, et al. Estimation of oncologists\u2019 active supply in iran: three sources Capture-Recapture method. Iran Red Crescent Med J (IRCMJ). 2017;19(7):1\u20138.","journal-title":"Iran Red Crescent Med J (IRCMJ)"},{"issue":"467","key":"1033_CR9","first-page":"96","volume":"36","author":"F Ashrafi","year":"2018","unstructured":"Ashrafi F, Nekouei SA, Moazzam E. The correlation between the serum level of free light chain ratio and prognostic factors among the patients with lymphoma. J Isfahan Med School. 2018;36(467):96\u2013103.","journal-title":"J Isfahan Med School"},{"key":"1033_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5501\/wjv.v1.i6.162","volume":"1","author":"S Datta","year":"2012","unstructured":"Datta S, Chatterjee S, Policegoudra R, Gogoi H, Singh L. Hepatitis viruses and non-Hodgkin\u2019s lymphoma: A review. World J Virol. 2012;1:162\u201373.","journal-title":"World J Virol"},{"issue":"1","key":"1033_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10198-019-01066-x","volume":"20","author":"V Brodszky","year":"2019","unstructured":"Brodszky V, Beretzky Z, Baji P, et al. Cost-of-illness studies in nine central and Eastern European countries. Eur J Health Econ. 2019;20(1):155\u201372.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"1033_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","volume":"77","author":"R Tarricone","year":"2006","unstructured":"Tarricone R. Cost-of-illness analysis. What room in health economics? Health Policy. 2006;77(1):51\u201363.","journal-title":"Health Policy"},{"key":"1033_CR13","doi-asserted-by":"publisher","DOI":"10.1201\/b19001","volume-title":"Design & analysis of clinical trials for economic evaluation & reimbursement: an applied approach using","author":"I Khan","year":"2015","unstructured":"Khan I. Design & analysis of clinical trials for economic evaluation & reimbursement: an applied approach using. SAS & STATA: CRC; 2015."},{"key":"1033_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/hec.3295","volume":"25","author":"L Cunnama","year":"2016","unstructured":"Cunnama L, Sinanovic E, Ramma L, Foster N, Berrie L, Stevens W, et al. Using top-down and bottom\u2010up costing approaches in lmics: the case for using both to assess the incremental costs of new technologies at scale. Health Econ. 2016;25:53\u201366.","journal-title":"Health Econ"},{"issue":"6","key":"1033_CR15","doi-asserted-by":"publisher","first-page":"e24311","DOI":"10.1002\/clc.24311","volume":"47","author":"A Tajik","year":"2024","unstructured":"Tajik A, Abbasi A, Goudarzi Z, Izadi-Moud A, Varmaghani M. Cost-Effectiveness and budget impact analysis of Apixaban and Rivaroxaban versus warfarin in the prevention of stroke in patients with Non-Valvular atrial fibrillation (NVAF) in Iran. Clin Cardiol. 2024;47(6):e24311.","journal-title":"Clin Cardiol"},{"issue":"1","key":"1033_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s13014-023-02327-z","volume":"18","author":"M Varmaghani","year":"2023","unstructured":"Varmaghani M, Amiri M, Ebrahimpour H, Salek R, Javan-Noughabi J. The cost effectiveness of intensity-modulated radiation therapy and three-dimensional conformal radiotherapy in the treatment of head and neck cancers. Radiat Oncol. 2023;18(1):138.","journal-title":"Radiat Oncol"},{"issue":"2","key":"1033_CR17","first-page":"94","volume":"18","author":"A Hashemi-Meshkini","year":"2023","unstructured":"Hashemi-Meshkini A, Tajik A, Ayati N, Nikfar S, Koochak R, Yaghoubifard S, et al. Cost-Effectiveness comparison between Ticagrelor and clopidogrel in acute coronary syndrome in Iran. J Tehran Heart Cent. 2023;18(2):94\u2013101.","journal-title":"J Tehran Heart Cent"},{"issue":"1","key":"1033_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clinthera.2018.11.001","volume":"41","author":"M Mojahedian","year":"2019","unstructured":"Mojahedian M, Toroski M, Keshavarz K, Aghili M, Zeyghami S, Nikfar S. Estimating the cost of illness of prostate cancer in Iran. Clin Ther. 2019;41(1):50\u20138.","journal-title":"Clin Ther"},{"issue":"10","key":"1033_CR19","doi-asserted-by":"publisher","first-page":"e26864","DOI":"10.1371\/journal.pone.0026864","volume":"6","author":"M Javanbakht","year":"2011","unstructured":"Javanbakht M, Baradaran HR, Mashayekhi A, Haghdoost AA, Khamseh ME, Kharazmi E, et al. Cost-of-illness analysis of type 2 diabetes mellitus in Iran. PLoS ONE. 2011;6(10):e26864.","journal-title":"PLoS ONE"},{"issue":"1","key":"1033_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.jdeveco.2005.01.004","volume":"80","author":"S McDonald","year":"2006","unstructured":"McDonald S, Roberts J. AIDS and economic growth: A human capital approach. J Dev Econ. 2006;80(1):228\u201350.","journal-title":"J Dev Econ"},{"issue":"1","key":"1033_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-023-09229-6","volume":"23","author":"T Reshadat-Hajiabad","year":"2023","unstructured":"Reshadat-Hajiabad T, Khajavi A, Hosseinpour AM, Bojdy A, Hashemi-Meshkini A, Varmaghani M. Determinants and economic burden of HIV\/AIDS in iran: a prospective study. BMC Health Serv Res. 2023;23(1):1\u20138.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"1033_CR22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.clinthera.2018.11.001","volume":"41","author":"MM Mojahedian","year":"2019","unstructured":"Mojahedian MM, Toroski M, Keshavarz K, Aghili M, Zeyghami S, Nikfar S. Estimating the cost of illness of prostate cancer in Iran. Clin Ther. 2019;41(1):50\u20138.","journal-title":"Clin Ther"},{"key":"1033_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/1477-7525-10-151","volume":"10","author":"SH Kim","year":"2012","unstructured":"Kim SH, Jo MW, Kim HJ, Ahn JH. Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients. Health Qual Life Outcomes. 2012;10:151.","journal-title":"Health Qual Life Outcomes"},{"issue":"4","key":"1033_CR24","first-page":"61","volume":"3","author":"A Safaee","year":"2008","unstructured":"Safaee A, Zeighami B, Tabatabaee H, MoghimiDehkordi B. Quality of life and related factors in breast cancer patients under chemotherapy. Iran J Epidemiol. 2008;3(4):61\u20136.","journal-title":"Iran J Epidemiol"},{"issue":"6","key":"1033_CR25","first-page":"400","volume":"7","author":"A Montazeri","year":"1999","unstructured":"Montazeri A, Harirchi I, Vahdani M, Khaleghi F, Jarvandi S, Ebrahimi M, et al. The EuropeanOrganization for research and treatment of cancer quality of life questionnaire (EORTC QLQC30): translation and validation study of the Iranian version. Support Care Cancer. 1999;7(6):400\u20136.","journal-title":"Support Care Cancer"},{"key":"1033_CR26","unstructured":"provider Group. Report of National cancer registry. Ministry of Health; 2009."},{"key":"1033_CR27","unstructured":"Mousavi S. Executive guideline for registering and reporting cancer cases tehran: cancer office and the research fellowship of cancer. Research Center of Cancer Institute; 2007. [."},{"key":"1033_CR28","doi-asserted-by":"crossref","unstructured":"Lee S, Knox A, Zeng IS, Coomarasamy C, Blacklock H, Issa SJSCC. Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost\u2013benefit and quality of life analysis. Support Care Cancer 2013;21:841\u20136.","DOI":"10.1007\/s00520-012-1589-2"},{"key":"1033_CR29","unstructured":"Arozullah AM, Calhoun EA, Wolf M, Finley DK, Fitzner KA, Heckinger EA et al. The financial burden of cancer: estimates from a study of insured women with breast cancer. J Support Oncol 2004;2(3):271\u20138."},{"issue":"2","key":"1033_CR30","first-page":"166","volume":"47","author":"A Aryankhesal","year":"2018","unstructured":"Aryankhesal A, Etemadi M, Mohseni M, Azami-Aghdash S, Nakhaei M. Catastrophic health expenditure in iran: a review Article. Iran J Public Health. 2018;47(2):166.","journal-title":"Iran J Public Health"},{"key":"1033_CR31","doi-asserted-by":"crossref","unstructured":"Romanus D, Neumann P, Earle C, Weinstein M, Tsai J, Neville B et al. Out-of-pocket costs (OPC) and time costs (TC) for patients with stage IV non-small cell lung cancer (NSCLC) and their caregivers. J Clin Oncol 2004;22(14_suppl):6021-.","DOI":"10.1200\/jco.2004.22.90140.6021"},{"issue":"6","key":"1033_CR32","first-page":"500","volume":"16","author":"C Longo","year":"2007","unstructured":"Longo C, Deber R, Fitch M, Williams A, D\u2019souza DJEjocc. An examination of cancer patients\u2019 monthly \u2018out-of\u2010pocket\u2019costs in Ontario. Canada. 2007;16(6):500\u20137.","journal-title":"Canada"},{"issue":"8","key":"1033_CR33","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1002\/cncr.20956","volume":"103","author":"JC Hornberger","year":"2005","unstructured":"Hornberger JC, Best JH. Cost utility in the united States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large B-cell lymphoma. Cancer. 2005;103(8):1644\u201351.","journal-title":"Cancer"},{"issue":"3","key":"1033_CR34","first-page":"841","volume":"21","author":"S Lee","year":"2013","unstructured":"Lee S, Knox A, Zeng IS, Coomarasamy C, Blacklock H, Issa S. Primary prophylaxis with granulocyte colony-stimulating factor (GCSF) reduces the incidence of febrile neutropenia in patients with non-Hodgkin lymphoma (NHL) receiving CHOP chemotherapy treatment without adversely affecting their quality of life: cost-benefit and quality of life analysis. Support Care Cancer. 2013;21(3):841\u20136.","journal-title":"Support Care Cancer"},{"key":"1033_CR35","doi-asserted-by":"crossref","unstructured":"Hjermstad MJ, Oldervoll L, Fossa SD, Holte H, Jacobsen AB, Loge JH. Quality of life in long-term Hodgkin\u2019s disease survivors with chronic fatigue. European journal of cancer (Oxford, England: 1990). 2006;42(3):327\u2013\u200933.","DOI":"10.1016\/j.ejca.2005.09.028"},{"issue":"5","key":"1033_CR36","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0959-8049(99)00025-8","volume":"35","author":"R Greil","year":"1999","unstructured":"Greil R, Holzner B, Kemmler G, Kopp M, Buchowski A, Oberaigner W, et al. Retrospective assessment of quality of life and treatment outcome in patients with hodgkin\u2019s disease from 1969 to 1994. Eur J Cancer (Oxford England: 1990). 1999;35(5):698\u2013706.","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"issue":"8","key":"1033_CR37","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1002\/cncr.22581","volume":"109","author":"F Mols","year":"2007","unstructured":"Mols F, Aaronson NK, Vingerhoets AJ, Coebergh JW, Vreugdenhil G, Lybeert ML, et al. Quality of life among long-term non-Hodgkin lymphoma survivors: a population-based study. Cancer. 2007;109(8):1659\u201367.","journal-title":"Cancer"},{"issue":"4","key":"1033_CR38","first-page":"226","volume":"24","author":"N Esmailnasab","year":"2013","unstructured":"Esmailnasab N, Taymoori P, Darabi F. Comparison of quality of life 3 and 9 months after surgery in patients with Gastrointestinal cancer. Stud Med Sci. 2013;24(4):226\u201334.","journal-title":"Stud Med Sci"},{"issue":"2","key":"1033_CR39","first-page":"109","volume":"1","author":"F Abdollahzadeh","year":"2012","unstructured":"Abdollahzadeh F, Aghahossini SS, Rahmani A, Kermani IA. Quality of life in cancer patients and its related factors. J Caring Sci. 2012;1(2):109.","journal-title":"J Caring Sci"},{"issue":"3","key":"1033_CR40","first-page":"0","volume":"6","author":"A Tavoli","year":"2007","unstructured":"Tavoli A, Montazeri A, Mohagheghi M, Roshan R, Tavoli Z, Melyani M. Knowledge of cancer diagnosis and quality of life in patients with Gastrointestinal cancer. Payesh (Health Monitor). 2007;6(3):0.","journal-title":"Payesh (Health Monitor)"},{"key":"1033_CR41","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1186\/s12889-015-2342-9","volume":"15","author":"R Dolatkhah","year":"2015","unstructured":"Dolatkhah R, Somi MH, Kermani IA, Ghojazadeh M, Jafarabadi MA, Farassati F, et al. Increased colorectal cancer incidence in iran: a systematic review and meta-analysis. BMC Public Health. 2015;15:997.","journal-title":"BMC Public Health"}],"container-title":["Journal of Health, Population and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41043-025-01033-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41043-025-01033-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T21:25:34Z","timestamp":1757366734000},"score":1,"resource":{"primary":{"URL":"https:\/\/jhpn.biomedcentral.com\/articles\/10.1186\/s41043-025-01033-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,6]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1033"],"URL":"https:\/\/doi.org\/10.1186\/s41043-025-01033-8","relation":{},"ISSN":["2072-1315"],"issn-type":[{"value":"2072-1315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,6]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research has been approved by the Medical Ethics Committee of MUMS (No. IR.MUMS.REC.1399.576). All participants provided a written informed consent form for the various aspects of data collection, which was implemented in accordance with the principles and regulations of confidentiality and privacy. All research methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}